Produced to the most demanding industry standards at dedicated facilities, Zephex® propellants are used in around 75% of the world’s metered dose inhalers.

This commitment to the highest levels of medical propellant quality is supported by a detailed understanding of customer requirements and experienced staff with many years of technical expertise.

Latest News

Koura to supply ground breaking low-carbon footprint medical propellant to Chiesi Farmaceutici for inhalation product development and clinical trials

Landmark multi-million-pound sterling commercial agreement will advance efforts to bring Zephex®152a from the laboratory to the patient   Runcorn (United Kingdom) December 2019 – Koura, the leading medical propellant manufacturer (previously known as Mexichem Fluor), has today announced a commercial agreement to supply the new…

Read More

Koura to showcase world-leading products at DDL 2019

Global innovators and world leaders in medical propellants, Koura, will showcase its industry-leading products at The Drug Delivery to the Lungs (DDL) Conference as a Gold Sponsor.

Read More

Koura are proud to be Gold Sponsor at Inhalation Asia 2019

Koura are Gold sponsors at 2019’s Inhalation Asia in Hong Kong this November 13th-15th

Read More